Paolo Boffetta

Last updated
Paolo Boffetta
Born (1958-07-19) July 19, 1958 (age 65)
Turin, Italy
Nationality Italian
Alma mater University of Turin
Known forResearch on cancer epidemiology
Scientific career
Fields Epidemiology
Institutions Stony Brook University, University of Bologna

Paolo Boffetta (born July 19, 1958) is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development.

Contents

Biography

A video of Paolo Boffetta discussing his research with the World Trade Center Health Program to reconstruct first responders' exposure to carcinogens during the September 11 attacks

Boffetta was born in Turin, Italy, went to the Vittorio Alfieri High School in Turin, and studied medicine at the University of Turin and received a Doctor of Medicine degree in 1982, after which he became a resident at the Second Division of Internal Medicine and research fellow and research assistant at the Cancer Epidemiology Unit of the University of Turin.

After some years, he moved to New York City and worked as a research assistant at the Department of Statistics and Epidemiology of the American Cancer Society (1986–88). He became a research assistant at the Division of Epidemiology of the American Health Foundation in New York, in 1988 and a graduate research assistant at the Division of Environmental Sciences and Post-Doctoral Associate at the Division of Health Policy and Management of Columbia University, School of Public Health in New York (1988–89), where he was awarded a M.P.H.

In 1990, he moved to Lyon, France, to join the International Agency for Research on Cancer, IARC, first as medical officer until 1994 and later as chief of the Unit of Environmental Cancer Epidemiology (1995–2003). During this time he was also visiting scientist at the Division of Cancer Epidemiology and Genetics, US National Cancer Institute, in Washington (1998/99), foreign adjunct professor, at the Department of Medical Epidemiology and Microbiology and Tumour Biology Centre, Karolinska Institutet, Stockholm, Sweden (2000–2006). [1]

In 2003, he moved on to the German Cancer Research Center in Heidelberg, Germany, where he headed the Division of Clinical Epidemiology. He was awarded a professorship for clinical epidemiology at the University of Heidelberg in the same year.

Only a year later Boffetta moved back to IARC, Lyon to become group head and coordinator of the Genetics and Epidemiology Cluster [2] there.

Between 2009 and 2020, he worked at Icahn School of Medicine at Mount Sinai in New York, NY, as professor, [3] associate director for global oncology at the Tisch Cancer Institute. During 2010-2016, he was director of the Institute for Translational Epidemiology.

In 2020 he joined Stony Brook University, where he is professor in the Department of Department of Family, Population & Preventive Medicine and associate director for population sciences at Stony Brook Cancer Center. Since 2018, he is professor at the Department of Medical and Surgical Sciences of the University of Bologna. [4]

He is adjunct professor at the Department of Epidemiology, Harvard School of Public Health, Boston, USA, [5] at the Department of Medicine, Vanderbilt University, [6] Nashville, US, at the Department of Public Health of the Catholic University in Rome, Italy, and at the Arnold School of Public Health, University of South Carolina.

He was vice president of the International Prevention Research Institute in Lyon during 2009-2013. [7] He regularly serves as chair or member of national and international committees, including in particular review committees of the US National Institute of Health and the National Academy of Sciences. He is a fellow of the European Academy of Cancer Sciences and the New York Academy of Medicine.

Scientific merits

Boffetta's specific field of research is the study of environmental factors for cancer. [8] He always was very much interested in international collaboration why he was founding member and member of the executive committee of the several international research consortia, e.g. Interlymph – Non-Hodgkin's Lymphoma consortium (2001–08), the ILCCO – Lung cancer consortium (2003-), the INHANCE – Head and neck cancer consortium (2004-), the PANC4 – Pancreatic cancer consortium, the StoP Project – Stomach cancer, and the ILCEC - liver cancer consortium. Currently Boffetta is involved in several case-control studies of molecular epidemiology in different organs and countries around the world. Paolo Boffetta is a Member of the Steering Committee of the Asia Cohort Consortium (ACC) [9] and was Chair of the Molecular Epidemiology Group (MEG) of the American Association for Cancer Research (AACR) (2008–2009). [10]

He has been heavily involved in teaching activities during all his academic and research positions; e.g., at IARC he held the post of Director, IARC Course Programme (2000–2003 and 2004–2009). He was also Director of the IARC Fellowship Programme (2004–2009) and a Member of the UICC Fellowship Committee (2000–2009). He is currently teaching advanced epidemiology methods and cancer epidemiology at the Icahn School of Medicine at Mount Sinai, University of Bologna, and Harvard School of Public Health.

Currently he is a Member of the editorial board of several scientific journals including Annals of Oncology (Associate Editor), Cancer Discovery, Frontiers in Molecular Epidemiology (Editor), International Archives of Occupational and Environmental Health, International Journal of Molecular Epidemiology and Genetics, Journal of the American College of Cardiology (Section Editor). He was the Editor in Chief of the 3rd Edition of Elsevier's Encyclopaedia of Cancer.

Paolo Boffetta has published more than 1,300 scientific articles and 80 book chapters as well as is editor of 15 books and journal supplements, and has authored several other non-English and non-scientific articles about various aspects of health. His H-index is 118 (Web of Science) and 173 (Google Scholar). [11] He is listed among the top 20 Italian scientists. [12]

Related Research Articles

Molecular epidemiology is a branch of epidemiology and medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations. This field has emerged from the integration of molecular biology into traditional epidemiological research. Molecular epidemiology improves our understanding of the pathogenesis of disease by identifying specific pathways, molecules and genes that influence the risk of developing disease. More broadly, it seeks to establish understanding of how the interactions between genetic traits and environmental exposures result in disease.

The Joseph L. Mailman School of Public Health is the public health graduate school of Columbia University. Located on the Columbia University Irving Medical Center campus in the Washington Heights neighborhood of Manhattan, New York City, the school is accredited by the Council on Education for Public Health.

<span class="mw-page-title-main">Joseph F. Fraumeni Jr.</span> American physician and cancer researcher

Joseph F. Fraumeni Jr. is an American physician and cancer researcher. Born in Boston, he received an A.B. from Harvard College, an M.D. from Duke University, and an M.Sc. in epidemiology from the Harvard School of Public Health. He completed his medical residency at Johns Hopkins Hospital and Memorial Sloan Kettering Cancer Center. He then joined the National Cancer Institute at the National Institutes of Health in 1962 as a commissioned officer of the U.S. Public Health Service, becoming the founding Director of the Division of Cancer Epidemiology and Genetics in 1995. He stepped down from this position in 2012 to become a senior investigator and advisor to the National Cancer Institute.

<span class="mw-page-title-main">Peter Boyle (epidemiologist)</span> British epidemiologist (1951–2022)

Peter Boyle, FRSE FFPH FRCPS(Glas) FRCP(Edin) FMedSci, was a British epidemiologist. He conducted research on globalisation of cancer, where he showed the dramatic increase of cancer in low- and medium income countries.

Philippe Autier is a Belgian epidemiologist. He is doing research on cancer, where he contributed to the understanding of the role of UV exposure in cancer development.

Carlo La Vecchia is an Italian epidemiologist. He is doing research on chronic diseases, where he contributed to the understanding of the risks related to diet, tobacco, oral contraceptive use and occupational or environmental exposure to toxic substances in cancer and other chronic diseases development.

Derek LeRoith is a South African endocrinologist and Professor of Medicine and the current Chief of the Hilda and J. Lester Gabrilove, M.D. Division of Endocrinology, Diabetes and Bone Disease and Director of the Metabolism Institute of the Mount Sinai Medical Center in New York City. He is an international expert in insulin-like growth factor-1 (IGF-1).

David A. Savitz is a professor of Community Health in the Epidemiology Section of the Program in Public Health, Vice President for Research, and Professor of Obstetrics and Gynecology, at The Alpert Medical School of Brown University, and Associate Director for Perinatal Research in The Department of Obstetrics and Gynecology at Women & Infants Hospital, both in Providence, Rhode Island. Savitz is the author of Interpreting epidemiologic evidence: strategies for study design and analysis (ISBN 0-19-510840-X) and more than 275 peer-reviewed articles. He was elected to the Institute of Medicine in 2007.

<span class="mw-page-title-main">Robert J. Desnick</span> American geneticist

Robert J. Desnick is an American human geneticist whose basic and translational research accomplishments include significant discoveries in genomics, pharmacogenetics, gene therapy, personalized medicine, and the treatment of genetic diseases. His translational research has led to the development of the enzyme replacement therapy (ERT) and the chaperone therapy for Fabry disease, ERT for Niemann–Pick disease type B, and the RNA Interference Therapy for the Acute Hepatic Porphyrias.

William K. Oh, is an American medical oncologist, academic and industry leader and expert in the management of genitourinary malignancies, including prostate, renal, bladder and testicular cancers.

<span class="mw-page-title-main">Ming-Ming Zhou</span>

Ming-Ming Zhou is an American scientist whose specification is structural and chemical biology, NMR spectroscopy, and drug design. He is the Dr. Harold and Golden Lamport Professor and Chairman of the Department of Pharmacological Sciences. He is also the co-director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System in New York City, as well as Professor of Sciences. Zhou is an elected fellow of the American Association for the Advancement of Science.

Clement Adebamowo is a Nigerian medical researcher and academic. Born in Lagos, Nigeria, Adebamowo is currently Director For Global Health Cancer Research, and a professor of Epidemiology & Public Health, at the University of Maryland School of Medicine. He is known for his work in cancer epidemiology, nutrition epidemiology, and research ethics, particularly in low resource and under-served in Africa.

<span class="mw-page-title-main">Lorenzo Tomatis</span> Italian oncologist (1929–2007)

Lorenzo (Renzo) Tomatis was an Italian physician and experimental oncologist who researched carcinogenesis and its primary prevention

<span class="mw-page-title-main">Leona D. Samson</span> Biological engineer (born 1952)

Leona D. Samson is the Uncas and Helen Whitaker Professor and American Cancer Society Research Professor of Biological Engineering at the Massachusetts Institute of Technology, where she served as the Director of the Center for Environmental Health Sciences from 2001 to 2012. Before her professorship at MIT, she held a professorship at the Harvard School of Public Health. She is on the editorial board of the journal DNA Repair. Her research interests focus on "methods for measuring DNA repair capacity (DRC) in human cells", research the National Institute of Health recognized as pioneering in her field, for which the NIH granted her the National Institutes of Health Director's Pioneer Award.

Paolo Vineis is an Italian professor of Environmental Epidemiology at Imperial College London.

<span class="mw-page-title-main">Curtis C. Harris</span> American cancer researcher

Curtis. C. Harris is the head of the Molecular Genetics and Carcinogenesis Section and chief of the Laboratory of Human Carcinogenesis at the Center for Cancer Research of the National Cancer Institute, NIH.

Cornelia "Neli" Ulrich is executive director of the Comprehensive Cancer Center at Huntsman Cancer Institute (HCI), Jon M. and Karen Huntsman Presidential Professor in Cancer Research, and former Division Chief of Cancer Population Sciences in the Department of Population Health Sciences at the University of Utah. Ulrich oversees HCI's academic consortium of nearly 200 cancer research teams. She leads efforts to advance the impact of HCI's research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment. Prior to joining HCI, she was the director and department head of preventive oncology at the National Center of Tumor Diseases (NCT) and German Cancer Research Center (DKFZ) in Heidelberg. During this time, she also held a Professorship at the DKFZ and University of Heidelberg. From 1993 until 2009, Ulrich was a Member of the Fred Hutchinson Cancer Research Center and Professor in Epidemiology at the University of Washington in Seattle.

Dafna Bar-Sagi is a cell biologist and cancer researcher at New York University School of Medicine. She is the Saul J. Farber Professor in the department of biochemistry and molecular pharmacology and the department of medicine and senior vice president and vice dean for science at NYU Langone Health. Bar-Sagi has been a member of scientific advisory boards, including the National Cancer Institute, Starr Cancer Consortium, and Pancreatic Cancer Action Network.

<span class="mw-page-title-main">Elisabete Weiderpass</span> Brazilian cancer researcher

Elisabete Weiderpass-Vainio is a Brazilian cancer researcher who is Director of the International Agency for Research on Cancer, a part of the World Health Organization. Her research considers the epidemiology and prevention of cancer.

Folakemi Titilayo Odedina is a Nigerian-born scientist and professor of pharmacy and medicine at the University of Florida. She is the principal investigator for the Prostate Cancer Transatlantic Consortium (CaPTC), a clinical research group using genomic science and environmental etiology to exploring disproportionate burden of prostate cancer among Black men funded by the NCI. She is a member of American Cancer Society's National Prostate Cancer Disparities Advisory Team.

References

  1. ↑ Newsletter MEP, KI
  2. ↑ Biographical sketch of Paolo Boffetta at IARC Archived 2010-04-13 at the Wayback Machine
  3. ↑ Contact details of Paolo Boffetta at the Mount Sinai School of Medicine Archived 2010-10-22 at the Wayback Machine
  4. ↑ "Paolo Boffetta — Università di Bologna — Home Page".
  5. ↑ Contact details of Paolo Boffetta at the Harvard School of Public Health
  6. ↑ Press release about new appointments at Vanderbilt University
  7. ↑ "Paolo Boffettas' biography on the website of International Prevention Research Institute". Archived from the original on 2010-10-03. Retrieved 2010-10-18.
  8. ↑ Abstract of Contribution of environmental factors to cancer risk, Br Med Bull. 2003;68:71-94.
  9. ↑ General Membership Meeting Agenda, ACC Archived 2011-07-25 at the Wayback Machine
  10. ↑ Conference about the Future of Molecular Epidemiology, AACR [ permanent dead link ]
  11. ↑ Paolo Boffetta's publications
  12. ↑ "Top Italian Scientists Home".
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.